[New antibiotics for treatment of MRSA infections. Comparison of treatment with vancomycin]. - Suppr | 超能文献

[New antibiotics for treatment of MRSA infections. Comparison of treatment with vancomycin].

作者信息

Burkhardt Olaf, Derendorf Hartmut, Welte Tobias

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville 32610, USA.

出版信息

Med Monatsschr Pharm. 2006 Feb;29(2):56-62; quiz 63-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[New antibiotics for treatment of MRSA infections. Comparison of treatment with vancomycin].

Med Monatsschr Pharm. 2006 Feb;29(2):56-62; quiz 63-4.

2

Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.用于治疗耐甲氧西林金黄色葡萄球菌感染的万古霉素替代药物。

Clin Infect Dis. 2007 Sep 15;45 Suppl 3:S184-90. doi: 10.1086/519471.

3

Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.耐甲氧西林金黄色葡萄球菌菌株中的抗生素耐药性不断增加。

Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S360-7. doi: 10.1086/533592.

4

Key considerations in the treatment of complicated staphylococcal infections.复杂性葡萄球菌感染治疗中的关键考量因素。

Clin Microbiol Infect. 2008 Mar;14 Suppl 2:3-9. doi: 10.1111/j.1469-0691.2008.01923.x.

5

Failure of vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections.万古霉素治疗耐甲氧西林金黄色葡萄球菌感染失败。

Clin Infect Dis. 2004 Nov 15;39(10):1544; author reply 1544-5. doi: 10.1086/425129.

6

Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.耐甲氧西林金黄色葡萄球菌的负担：关注临床和经济结果。

Pharmacotherapy. 2007 Jul;27(7):1001-12. doi: 10.1592/phco.27.7.1001.

7

Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?金黄色葡萄球菌引起的严重感染的治疗：万古霉素治疗模式的改变？

Shock. 2008 Oct;30 Suppl 1:67-9. doi: 10.1097/SHK.0b013e318181a6e4.

8

Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin.用于治疗对万古霉素敏感性降低的耐甲氧西林金黄色葡萄球菌菌株引起的侵袭性感染的替代药物。

Arch Intern Med. 2007 Jun 11;167(11):1206; author reply 1208-9. doi: 10.1001/archinte.167.11.1206-a.

9

[The Dutch MRSA policy should be retained].应保留荷兰的耐甲氧西林金黄色葡萄球菌（MRSA）政策。

Ned Tijdschr Geneeskd. 2006 Aug 26;150(34):1884.

10

Treatment of MRSA infections with older molecules: a reasonable option for investigation.用较老的分子治疗耐甲氧西林金黄色葡萄球菌感染：一个值得研究的合理选择。

Arch Intern Med. 2007 Jun 11;167(11):1207-8; author reply 1208-9. doi: 10.1001/archinte.167.11.1207-b.

引用本文的文献

1

[Management of nosocomial pneumonia-state of the art].[医院获得性肺炎的管理——最新进展]

Intensivmed Notfallmed. 2006;43(4):301-309. doi: 10.1007/s00390-006-0721-2.